腦積水流器市場- 產品（瓣膜[可調節、固定]、導管）、程序（腦室腹膜、腰腹膜、心室心房、腦室胸膜）、年齡層（兒科、成人）、最終用途（醫院、ASC） 、全球預測（2024 - 2032）

由於腦積水和相關神經系統疾病盛行率不斷增加，2024-2032 年腦積水流器市場規模的複合年成長率可能為 3.5%。據報道，全世界每年約有 40 萬名兒童被診斷出患有腦積水。腦積水（包括先天性和後天性腦積水）的發病率上升，特別是在兒童和老年族群中，正在增加分流裝置的需求。診斷技術的進步和醫療保健提供者意識的提高也將有助於早期發現和治療。

現代腦積水分流器採用增強材料和先進機制，具有更好的生物相容性、可靠性和易用性。可程式閥門和遠端監控功能等創新也改善了患者的治療效果和便利性，使這些設備對醫療保健專業人員更具吸引力。旨在完善分流技術和擴大應用的加強研發力度將促進市場成長。

該行業分為產品、程序類型、年齡層、最終用途和地區。

從產品來看，由於其有效性和功能性，腦積水導管領域的腦積水分流市場將在 2032 年之前顯著成長。導管技術的進步，例如改進的材料和設計創新，也增強了生物相容性並降低了併發症的風險，進一步促進了其越來越多的採用。

腰腹腔手術類型細分市場的腦積水流量市場預計在 2024 年至 2032 年間產生大量收入，因為它們可以有效管理傳統腦室腹腔分流術較不適合的情況。腰部腹腔 (LP) 分流器能夠將腦脊髓液從腰部轉移到腹腔，為液體管理提供了另一種方法，使其成為複雜病例中的一個有價值的選擇。

由於醫療基礎設施的快速改善和醫療技術投資的增加，到 2032 年，亞太地區腦積水流量產業規模將以複合年成長率大幅成長。隨著一些國家正在加強其醫療保健系統並擴大獲得先進治療的機會，腦積水患者可以獲得更多的專門護理。旨在改善醫療設施和補貼治療費用的政府措施和醫療保健政策也將有助於推動區域市場的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 先天性腦積水盛行率增加
    • 人們對腦積水手術治療的認知不斷提高
    • 腦積水治療的報銷範圍
    • 老年人口增加
  • 產業陷阱與挑戰
    • 新興國家缺乏進行複雜神經外科手術的基礎設施
    • 腦積水流手術和後續護理相關的高成本
• 成長潛力分析
• 監管環境
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032

• 主要趨勢
• 腦積水瓣膜
  • 可調壓力閥
  • 定壓閥
• 腦積水導管
  • 標準導管
  • 抗菌導管

第 6 章：市場估計與預測：按程序類型，2021 - 2032 年

• 主要趨勢
• 腦室腹膜
• 腰腹膜
• 心室房
• 腦室胸膜

第 7 章：市場估計與預測：按年齡層別分類，2021 - 2032

• 主要趨勢
• 兒科
• 成人

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 醫院
• 門診手術中心

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 10 章：公司簡介

• B. Braun Melsungen AG
• CHRISTOPH MIETHKE GMBH & CO. KG
• DESU MEDIKAL A.S.
• G. Surgiwear Ltd.
• Hpbio
• Integra LifeSciences Corporation
• Kaneka Medix Corp.
• Luciole Medical AG
• Medtronic plc
• Natus Medical Incorporated
• SOPHYSA
• TKB Corporation

Hydrocephalus shunt market size is likely to register a 3.5% CAGR from 2024-2032 driven by the increasing prevalence of hydrocephalus and related neurological conditions. As per reports, annually around 400,000 children worldwide are diagnosed with hydrocephalus. The rising incidence of hydrocephalus, including both congenital and acquired forms, particularly in pediatric and elderly populations, is boosting the demand for shunt devices. Advances in diagnostic techniques and increased awareness among healthcare providers will also contribute to earlier detection and treatment.

Modern hydrocephalus shunts feature enhanced materials and advanced mechanisms for better bio-compatibility, reliability, and ease of use. Innovations, such as programmable valves and remote monitoring capabilities are also offering improved patient outcomes and convenience, making these devices more attractive to healthcare professionals. Increased R&D efforts aimed at refining shunt technologies and expanding applications will add to the market growth.

The industry is segmented into product, procedure type, age group, end-use, and region.

Based on product, the hydrocephalus shunt market from the hydrocephalus catheters segment will record a significant growth rate through 2032 due to their effectiveness and functionality. Advancements in catheter technology, such as improved materials and design innovations are also enhancing bio-compatibility and reducing the risk of complications, further contributing to their increasing adoption.

Hydrocephalus shunt market from the lumboperitoneal procedure type segment is poised to generate substantial revenue between 2024 and 2032 owing to their effectiveness in managing conditions where traditional ventriculoperitoneal shunts are less suitable. The ability of lumboperitoneal (LP) shunts to divert cerebrospinal fluid from the lumbar region to the peritoneal cavity provides an alternative approach to fluid management, making them a valuable option in complex cases.

Asia Pacific hydrocephalus shunt industry size will grow at a substantial CAGR through 2032 attributed to the rapidly improving healthcare infrastructure and increased investments in medical technologies. As several countries are enhancing their healthcare systems and expanding access to advanced treatments, there is greater availability of specialized care for hydrocephalus patients. Government initiatives and healthcare policies aimed at improving medical facilities and subsidizing treatment costs will also help in driving the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of congenital hydrocephalus
    • 3.2.1.2 Growing awareness towards surgical treatment of hydrocephalus
    • 3.2.1.3 Availability of reimbursement coverage for hydrocephalus treatments
    • 3.2.1.4 Increasing geriatric population
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of infrastructure for performing complex neurosurgeries in emerging countries
    • 3.2.2.2 High cost associated to hydrocephalus shunt surgery and follow-up care
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hydrocephalus valves
  • 5.2.1 Adjustable pressure valves
  • 5.2.2 Fixed pressure valves
• 5.3 Hydrocephalus catheters
  • 5.3.1 Standard catheters
  • 5.3.2 Antimicrobial catheters

Chapter 6 Market Estimates and Forecast, By Procedure type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Ventriculoperitoneal
• 6.3 Lumboperitoneal
• 6.4 Ventriculoatrial
• 6.5 Ventriculopleural

Chapter 7 Market Estimates and Forecast, By Age group, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pediatric
• 7.3 Adult

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgery centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 B. Braun Melsungen AG
• 10.2 CHRISTOPH MIETHKE GMBH & CO. KG
• 10.3 DESU MEDIKAL A.S.
• 10.4 G. Surgiwear Ltd.
• 10.5 Hpbio
• 10.6 Integra LifeSciences Corporation
• 10.7 Kaneka Medix Corp.
• 10.8 Luciole Medical AG
• 10.9 Medtronic plc
• 10.10 Natus Medical Incorporated
• 10.11 SOPHYSA
• 10.12 TKB Corporation